FERRER MEDICAL INNOVATIONS LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2020-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-III
Phase 2
Completed
- Conditions
- COVID-19COVID-19 PandemicCoronavirus InfectionsCoronavirus Disease 2019Symptoms and Signs
- First Posted Date
- 2023-06-02
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- Dr. Ferrer BioPharma
- Target Recruit Count
- 157
- Registration Number
- NCT05886829
- Locations
- 🇭🇳
Hospital CEMESA, Cortés, San Pedro Sula, Honduras
Accelerating COVID-19 Clinical Recovery in the Outpatient Setting: Retrospective Analysis
- Conditions
- COVID-19 PandemicCOVID-19 Respiratory InfectionSARS-CoV-2 Acute Respiratory DiseaseCOVID-19SARS CoV 2 Infection
- Interventions
- Drug: ClorNovir® (Chlorpheniramine) 0.4% Nasal Spray
- First Posted Date
- 2022-08-30
- Last Posted Date
- 2022-08-30
- Lead Sponsor
- Dr. Ferrer BioPharma
- Target Recruit Count
- 1000
- Registration Number
- NCT05520944
- Locations
- 🇩🇴
Clinica Union Medica, Santiago De Los Caballeros, Dominican Republic
Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-I
Phase 2
Completed
- Conditions
- Symptoms and SignsCoronavirus Disease 2019COVID-19COVID-19 PandemicCoronavirus Infections
- First Posted Date
- 2022-07-08
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Dr. Ferrer BioPharma
- Target Recruit Count
- 101
- Registration Number
- NCT05449405
- Locations
- 🇭🇳
Hospital CEMESA, Cortés, San Pedro Sula, Honduras
News
No news found